Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mishra, Biswaranjan
- Atrial Fibrillation: Pertinent to Practitioners
Abstract Views :186 |
PDF Views:0
Authors
Affiliations
1 Max Diagnostics, Ranihat, Cuttack, Odisha, IN
1 Max Diagnostics, Ranihat, Cuttack, Odisha, IN
Source
The Indian Practitioner, Vol 71, No 2 (2018), Pagination: 34-42Abstract
With increasing longevity and decreased mortality of cardiovascular diseases, atrial fibrillation (AF) has emerged as one of the important public health problems. AF is the most common sustained cardiac arrhythmia, prevalence of which increases with age. Prevalence of AF is approximately 3% in adults aged 20 years or older. It complicates almost all cardiac diseases sooner or later producing not only symptomatic deterioration but sharply increasing morbidity and mortality. Although a simple bedside ECG has remained the gold standard in the diagnosis of this arrhythmia for more than a century, advances in Echocardiography, advanced imaging techniques and electrophysiology has greatly facilitated the assessment of the underlying cardiac pathophysiologic state. Presentation of AF may vary from palpitation to a disabling embolism, the prevention of which is of paramount importance. Management approaches of AF are broadly based on heart rate control, restoration to sinus rhythm and anti-coagulation to prevent a thrombus formation. Oral anti-coagulation (OAC) with vitamin K antagonists significantly reduce stroke rate. Recent availability of newer oral anti-coagulants (NOACs) has increased the safety and efficacy of OAC. Development of clinical scoring systems for assessing risk of thrombosis and bleeding, such as CHA2DS2VASC and HAS-BLED scores, has greatly aided in decision making for giving or withholding OAC. Similarly therapeutic advances like catheter ablation and left atrial appendage occlusion have immensely improved the outcome of patients suffering from AF which otherwise have a poor prognosis.Keywords
Arrhythmia, Stroke, Oral Anticoagulants, Vitamin K Antagonist, NOAC.References
- Benjamin EJ,Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–952.
- Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837–847.
- Raja DC, Kapoor A. Epidemiology of Atrial Fibrillation-An Indian Perspective. J assoc Physicians of India.2016 Aug;64(supplement):7-10
- Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:154–162.
- Hijazi Z, Oldgren J, Siegbahn A, Granger CB,Wallentin L. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J 2013;34:1475–1480.
- Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864–2870.
- Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, Lip GY, Narkiewicz K, Parati G, Redon J, Schmieder R, Tsioufis C, Mancia G. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension. J Hypertens 2012;30:239–252.
- Xiong Q, Proietti M, Senoo K, Lip GY. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. Int J Cardiol 2015;191:172–177.
- Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, Lederlin M, Mondillo S, Edvardsen T, Sitges M, Grapsa J, Garbi M, Senior R, Gimelli A, Potpara TS, Van Gelder IC, Gorenek B, Mabo P, Lancellotti P, Kuck KH, Popescu BA, Hindricks G, Habib G, Cosyns B, Delgado V, Haugaa KH, Muraru D, Nieman K, Cohen A. EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging 2016;17:355–383.
- Kirchhof P et al, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS; European Heart Journal (2016) 37, 2893–2962.
- Wyse DG, Van Gelder IC, Ellinor PT, Go AS, Kalman JM, Narayan SM, Nattel S, Schotten U, Rienstra M. Lone atrial fibrillation: does it exist? J Am Coll Cardiol 2014; 63:1715–1723.
- Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol 2014;64:2222–2231.
- Nikolaidou T, Channer KS. Chronic atrial fibrillation: a systematic review of medical heart rate control management. Postgrad Med J 2009;85:303–312.
- Chatterjee NA, Upadhyay GA, Ellenbogen KA, McAlister FA, Choudhry NK, Singh JP. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circ Arrhythm Electrophysiol 2012;5:68–76.
- Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G. Outpatient treatment of recentonset atrial fibrillation with the “pill-in-the-pocket” approach. N Engl J Med 2004;351: 2384–2391.
- Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 2011;13:329–345.
- Philippart R, Brunet-Bernard A, Clementy N, Bourguignon T, Mirza A, Babuty D,Angoulvant D, Lip GY, Fauchier L. Prognostic value of CHA2DS2VASc score in patients with ‘non-valvular atrial fibrillation’ and valvular heart disease: the Loire Valley Atrial Fibrillation Project. Eur Heart J 2015;36:1822– 1830.
- Lip GY, Al-Khatib SM, Cosio FG, Banerjee A, Savelieva I, Ruskin J, Blendea D, Nattel S, De Bono J, Conroy JM, Hess PL, Guasch E, Halperin JL, Kirchhof P, MD GC, Camm AJ. Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? J Am Heart Assoc 2014;3:e001179.
- Sjogren V, Grzymala-Lubanski B, Renlund H, Friberg L, Lip GY, Svensson PJ, Sjalander A. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula. Thromb Haemost 2015;113:1370–1377.
- Olesen JB, Sorensen R, Hansen ML, Lamberts M,Weeke P, Mikkelsen AP, Kober L, Gislason GH, Torp-Pedersen C, Fosbol EL. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011–2013. Europace 2015;17:187–193.
- Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093–1100.
- Bajaj NS, Parashar A, Agarwal S, Sodhi N, Poddar KL, Garg A, Tuzcu EM, Kapadia SR. Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. JACC Cardiovasc Interv 2014;7:296–304.
- Treadmill Test - Changing Paradigm
Abstract Views :110 |
PDF Views:0
Authors
Affiliations
1 Senior consultant cardiologist, Max Diagnostic, IN
2 PG resident 1st Year, Dept of Anaesthesiology, D.Y. Patil Hospital, IN
1 Senior consultant cardiologist, Max Diagnostic, IN
2 PG resident 1st Year, Dept of Anaesthesiology, D.Y. Patil Hospital, IN
Source
The Indian Practitioner, Vol 76, No 1 (2023), Pagination: 7-12Abstract
Exercise or stress ECG referred to as treadmill test (TMT) has been used for the last several decades for the diagnosis of obstructive coronary artery disease (CAD) but is limited by its low sensitivity and specificity. The advent of other modalities which combines imaging such as echocardiography, nuclear perfusion imaging, computed tomography (CT), and magnetic resonance imaging (MRI) is highly sensitive and specific for the diagnosis of myocardial ischemia. Anatomic imaging of coronary arterial obstruction by CT angiography has also emerged as a highly sensitive and specific test to rule out CAD. TMT now moved from diagnosis of myocardial ischemia to assessment of valvular heart disease, congenital heart disease, pulmonary hypertension, arrhythmia, diastolic dysfunction, genetic CV disease, and peripheral arterial disease. It remains an important test for assessing exercise-induced symptoms, functional capacity, exercise duration, heart rate, and blood pressure during exercise and during recovery after exercise. Of its low sensitivity and specificity TMT should be avoided as a routine test in asymptomatic individuals and in persons with a low probability of CAD. However, due to its wide availability, low-cost and easy interpretation, when used judiciously in cases of moderate to a high probability of CAD, it remains invaluable.Keywords
Exercise ECG, Stress ECG, TMT, myocardial ischemia, stable coronary artery disease.References
- Russek HI. Master Two-Step Test in Coronary Artery Disease. JAMA. 1957;165(14):1772–75. DOI:10.1001/jama. 1957.02980320002002.
- Bruce RA. Evaluation of functional capacity and exercise tolerance of cardiac patients. Mod Concepts Cardiovasc Dis. 1956 Apr;25(4):321-6. PMID: 13309189.
- Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020 Apr 9;382(15):1395-1407. DOI:10.1056/ NEJMoa1915922. PMID: 32227755; PMCID: PMC7263833.
- Jeong HC, Kim I, Park KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kim YH, Seon HJ, Moon JD, Ahn Y. New strategy for detection of subclinical coronary atherosclerosis in asymptomatic patients with type 2 diabetes based on cardiac multi-detector computed tomography and treadmill test. Circ J. 2014;78(3):671-8. DOI: 10.1253/circj.cj13-1038. PMID: 24401570.
- Bourque JM, Beller GA. Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies. JACC Cardiovasc Imaging. 2015 Nov;8(11):1309-21. DOI: 10.1016/j.jcmg.2015.09.006. PMID: 26563861; PMCID: PMC4646721.
- Geleijnse ML, Krenning BJ, van Dalen BM, Nemes A, Soliman OI, Bosch JG, Galema TW, ten Cate FJ, Boersma E. Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography. J Am Soc Echocardiogr. 2009 Nov;22(11):1199-208. DOI: 10.1016/j.echo.2009.07.006. Epub 2009 Sep 18. PMID: 19766453.
- Fox K, Achenbach S, Bax J, Cosyns B, Delgado V, Dweck MR, Edvardsen T, Flachskampf F, Habib G, Lancellotti P, Muraru D, Neglia D, Pontone G, Schwammenthal E, Sechtem U, Westwood M, Popescu BA. Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging. Eur Heart J. 2019 Feb 7;40(6):553- 558. DOI: 10.1093/eurheartj/ehy669. PMID: 30380037
- Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, Berman DS. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013 Mar 12;61(10):1054- 65. DOI: 10.1016/j.jacc.2012.11.056. PMID: 23473411.
- Kumar D, Sethi RS, Bansal S, Namgyal PA, Sehgal AK, Malik TS. Diagnostic Accuracy of Stress Myocardial Perfusion Imaging in Indian Diabetic Patients: A Single Centre Experience. Indian J Nucl Med. 2017 Jul-Sep;32(3):177-183. DOI: 10.4103/0972-3919.207873. PMID: 28680199; PMCID: PMC5482011.
- Truong QA, Schulman-Marcus J, Zakroysky P, et al. Coronary CT Angiography Versus Standard Emergency Department Evaluation for Acute Chest Pain and Diabetic Patients: Is There Benefit With Early Coronary CT Angiography? Results of the Randomized Comparative Effectiveness ROMICAT II Trial. J Am Heart Assoc. 2016 Mar 22;5(3):e003137. DOI: 10.1161/JAHA.115.003137. PMID: 27006119; PMCID: PMC4943281
- Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002 Oct 16;40(8):1531-40. DOI: 10.1016/ s0735-1097(02)02164-2. Erratum in: J Am Coll Cardiol. 2006 Oct 17;48(8):1731. PMID: 12392846.
- Samad Z, Hakeem A, Mahmood SS, Pieper K, Patel MR, Simel DL, Douglas PS. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department. J Nucl Cardiol. 2012 Apr;19(2):364- 76. DOI: 10.1007/s12350-012-9520-2. PMID: 22322526.
- Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP. et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Nov 30;144(22):e368-e454. DOI: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28. Erratum in: Circulation. 2021 Nov 30;144(22):e455. PMID: 34709879.
- Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228. DOI: 10.1016/j. jacc.2014.09.017. Epub 2014 Sep 23. Erratum in: J Am Coll Cardiol. 2014 Dec 23;64(24):2713-4. PMID: 25260718.
- Task Force M, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013 Oct;34(38):2949-3003. DOI: 10.1093/eurheartj/ eht296. Epub 2013 Aug 30. Erratum in: Eur Heart J. 2014 Sep 1;35(33):2260-1. PMID: 23996286.
- Mieres JH, Gulati M, Bairey Merz N. et al. American Heart Association Cardiac Imaging Committee of the Council on Clinical Cardiology; Cardiovascular Imaging and Intervention Committee of the Council on Cardiovascular Radiology and Intervention. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation. 2014 Jul 22;130(4):350-79. DOI: 10.1161/CIR.0000000000000061. Epub 2014 Jun 16. Erratum in: Circulation. 2014 Jul 22;130(4):e86. PMID: 25047587.
- Baskaran L, Danad I, Gransar H, Ó Hartaigh B, SchulmanMarcus J, Lin FY, Peña JM, Hunter A, Newby DE, Adamson PD, Min JK. A Comparison of the Updated DiamondForrester, CAD Consortium, and CONFIRM HistoryBased Risk Scores for Predicting Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: The SCOT-HEART Coronary CTA Cohort. JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 2):1392-1400. DOI: 10.1016/j.jcmg.2018.02.020. Epub 2018 Apr 18. PMID: 29680338.
- van de Sande DA, Breuer MA, Kemps HM. Utility of Exercise Electrocardiography in Pre-participation Screening in Asymptomatic Athletes: A Systematic Review. Sports Med. 2016 Aug;46(8):1155-64. DOI: 10.1007/s40279-016-0501-5. PMID: 26893099.
- Moyer VA; U.S. Preventive Services Task Force. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Oct 2;157(7):512-8. DOI: 10.7326/0003- 4819-157-7-201210020-00514. PMID: 22847227.
- Acampa W, Assante R, Zampella E. The role of treadmill exercise testing in women. J Nucl Cardiol. 2016 Oct;23(5):991- 96. DOI: 10.1007/s12350-016-0596-y. Epub 2016 Jul 25. PMID: 27457528.
- Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-77. DOI: 10.1093/eurheartj/ ehz425. Erratum in: Eur Heart J. 2020 Nov 21;41(44):4242. PMID: 31504439
- Pais P. Treadmill stress tests should not be part of “routine health check package”. Indian Heart J. 2018 NovDec;70(6):934-36. DOI: 10.1016/j.ihj.2018.09.010. Epub 2018 Oct 12. PMID: 30580868; PMCID: PMC6306354.
- Maculewicz E, Pabin A, Kowalczuk K, Dziuda Ł, Białek A. Endogenous Risk Factors of Cardiovascular Diseases (CVDs) in Military Professionals with a Special Emphasis on Military Pilots. J Clin Med. 2022 Jul 25;11(15):4314. DOI: 10.3390/ jcm11154314. PMID: 35893405; PMCID: PMC9332217.
- Fletcher GF, Ades PA, Kligfield P, et al. American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013 Aug 20;128(8):873-934. DOI: 10.1161/CIR.0b013e31829b5b44. Epub 2013 Jul 22. PMID: 23877260.
- Miller TD, Askew JW, Anavekar NS. Noninvasive Stress Testing for Coronary Artery Disease. Heart Fail Clin. 2016 Jan;12(1):65-82. DOI: 10.1016/j.hfc.2015.08.006. PMID: 26567975.
- Fuller CM, Raizner AE, Verani MS, Nahormek PA, Chahine RA, McEntee CW, Miller RR. Early post-myocardial infarction treadmill stress testing. An accurate predictor of multivessel coronary disease and subsequent cardiac events. Ann Intern Med. 1981 Jun;94(6):734-9. DOI: 10.7326/0003-4819-94- 6-734. PMID: 7235413.
- Henri C, Piérard LA, Lancellotti P, Mongeon FP, Pibarot P, Basmadjian AJ. Exercise testing and stress imaging in valvular heart disease. Can J Cardiol. 2014 Sep;30(9):1012-26. DOI: 10.1016/j.cjca.2014.03.013. Epub 2014 Mar 15. PMID: 25151284.
- Wasserman K, Hansen JE, Sue DY, Whipp BJ, Froelicher VF. Principles of exercise testing and interpretation. Journal of Cardiopulmonary Rehabilitation and Prevention. 1987 Apr 1;7(4):189.
- Glaab T, Taube C, Practical guide to cardiopulmonary exercise testing in adults. Respir Res 23, 9 (2022). https://doi. org/10.1186/s12931-021-01895-6